878539-31-2

Basic information

• Product Name: (1S)-1-(3-BROMOPHENYL)-2,2,2-TRIFLUOROETHYLAMINE
• Synonyms: (1S)-1-(3-BROMOPHENYL)-2,2,2-TRIFLUOROETHYLAMINE;(S)-1-(3-BROMO-PHENYL)-2,2,2-TRIFLUORO-ETHYLAMINE;(1S)-1-(3-Bromophenyl)-2,2,2-trifluoroethan-1-amine
• CAS NO: 878539-31-2
• Molecular Formula: C8H7BrF3N
• Molecular Weight: 254.05
• Mol File: 878539-31-2.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (1S)-1-(3-BROMOPHENYL)-2,2,2-TRIFLUOROETHYLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: (1S)-1-(3-BROMOPHENYL)-2,2,2-TRIFLUOROETHYLAMINE(878539-31-2)
• EPA Substance Registry System: (1S)-1-(3-BROMOPHENYL)-2,2,2-TRIFLUOROETHYLAMINE(878539-31-2)

Safety Data

• Hazardous Substances Data: 878539-31-2(Hazardous Substances Data)

Usage

General Description

The chemical compound "(1S)-1-(3-Bromophenyl)-2,2,2-trifluoroethylamine" is an organic compound that belongs to the class of amines. It contains a trifluoroethylamine group and a bromophenyl group, making it a halogenated amine. (1S)-1-(3-BROMOPHENYL)-2,2,2-TRIFLUOROETHYLAMINE has potential applications in chemical synthesis, pharmaceuticals, and organic chemistry research. It may be used as a building block for the synthesis of various organic compounds and pharmaceutical intermediates. Its unique structure and functional groups make it a valuable compound in the field of organic chemistry.

Upstream product

• 655-26-5 m-bromotrifluoroacetone 

Relevant articles and documents

IMIDAZO [1,5-A]PYRIMIDINYL CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS

The invention provides substituted imidazo[1,5-a]pyrimidinyl carboxamide and related organic compounds, compositions containing such compounds, medical kits, and methods for using such compounds and compositions to treat medical disorders, e.g., Gaucher disease, Parkinson's disease, Lewy body disease, dementia, or multiple system atrophy, in a patient. Exemplary substituted imidazo[1,5-a]pyrimidinyl carboxamide compounds described herein include substituted 2-heterocyclyl-4-alkyl-imidazo[1,5-a]pyrirnidine-8-carboxamide compounds and variants thereof.

THERAPEUTIC INHIBITORY COMPOUNDS

The invention provides compounds of Formula I and Formula II: A-B-C-D-E-F-G-J (I) C-D-E-F-G-J (II) wherein A, B, C, D, E, F, G, and J have any of the values defined in the specification, and salts thereof. The compounds are useful for inhibiting plasma kallikrein, and for treating a disease or condition in an animal where inhibition of plasma kallikrein is indicated.